| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 781.42B | 768.13B | 721.09B | 720.58B | 713.77B | 768.11B |
| Gross Profit | 224.36B | 222.87B | 209.59B | 210.88B | 209.68B | 225.64B |
| EBITDA | 33.66B | 33.51B | 25.44B | 28.13B | 31.73B | 37.00B |
| Net Income | 14.30B | 14.12B | 9.02B | 11.39B | 13.11B | 16.63B |
Balance Sheet | ||||||
| Total Assets | 446.54B | 434.83B | 431.69B | 369.37B | 377.97B | 386.43B |
| Cash, Cash Equivalents and Short-Term Investments | 10.83B | 8.83B | 12.01B | 13.23B | 29.89B | 43.07B |
| Total Debt | 73.25B | 81.77B | 91.21B | 46.02B | 55.56B | 56.77B |
| Total Liabilities | 215.74B | 211.89B | 216.78B | 167.71B | 178.48B | 192.58B |
| Stockholders Equity | 230.34B | 222.52B | 214.61B | 201.66B | 199.48B | 193.84B |
Cash Flow | ||||||
| Free Cash Flow | 17.23B | 21.38B | -46.47B | 6.72B | 3.13B | 37.41B |
| Operating Cash Flow | 26.84B | 30.71B | 19.96B | 12.14B | 10.58B | 42.96B |
| Investing Cash Flow | -15.70B | -15.43B | -68.72B | -8.34B | -10.52B | -7.97B |
| Financing Cash Flow | -9.90B | -18.46B | 47.53B | -20.45B | -13.24B | -7.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥27.11B | 8.12 | ― | 3.77% | 7.88% | -5.92% | |
71 Outperform | ¥332.18B | 8.84 | ― | 1.35% | 15.92% | 52.76% | |
66 Neutral | ¥295.38B | 14.98 | 11.17% | 2.61% | 5.63% | 25.64% | |
65 Neutral | ¥225.18B | 18.16 | ― | 2.23% | 3.24% | 12.49% | |
64 Neutral | ¥438.25B | 9.24 | 4.18% | 2.57% | 1.26% | 14.65% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥249.00B | 19.39 | ― | 2.72% | 2.23% | 57.10% |